Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CHPG sodium salt is a selective agonist of mGluR5 and activates the ERK and Akt signaling pathways. CHPG sodium salt can be used in studies about traumatic brain injury.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 38.00 | |
5 mg | In stock | $ 89.00 | |
10 mg | In stock | $ 132.00 | |
25 mg | 6-8 weeks | $ 220.00 | |
50 mg | 6-8 weeks | $ 328.00 |
Description | CHPG sodium salt is a selective agonist of mGluR5 and activates the ERK and Akt signaling pathways. CHPG sodium salt can be used in studies about traumatic brain injury. |
In vitro | After the treatment of SO2 derivatives, CHPG sodium salt (10-500 µM) increases the cell viability and decreases the release of LDH. CHPG sodium salt (0.5 mM) prevents SO2-induced apoptosis and increases the expression of TSG-6 through TSG-6/NF-κB pathway in BV2 cells[1]. |
In vivo | In Sprague-Dawley male rats, injection of CHPG sodium salt (250 nM) reduces the cerebral lesion volume significantly[2]. |
Molecular Weight | 223.59 |
Formula | C8H7ClNNaO3 |
CAS No. | 1303993-73-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 6.0 mg/mL (26.8 mM), Sonification and heating to 80℃ are recommended.
DMSO: 90.0 mg/mL (402.5 mM), Sonification is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CHPG sodium salt 1303993-73-8 Neuroscience NF-Κb GluR NF-κB CHPG sodium inhibitor inhibit